Literature DB >> 12368061

Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy.

Stephen J Getting.   

Abstract

alpha-Melanocyte stimulating hormone (alpha-MSH) and other melanocortin peptides are potent anti-inflammatory agents that exhibit efficacy in many animal models of acute and chronic inflammation. These peptides are produced both centrally and peripherally, and exert their biological actions via activation of membrane-bound receptors. To exploit the therapeutic potential of such anti-inflammatory peptides, it is essential that the receptor subtype mediating these effects is identified with certainty.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368061     DOI: 10.1016/s0165-6147(02)02103-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  15 in total

1.  Impaired phagocytic mechanism in annexin 1 null macrophages.

Authors:  Simon Yona; Sigrid E M Heinsbroek; Leanne Peiser; Siamon Gordon; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH2 Template.

Authors:  Aleksandar Todorovic; Cody J Lensing; Jerry Ryan Holder; Joseph W Scott; Nicholas B Sorensen; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-06-11       Impact factor: 4.418

3.  Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways.

Authors:  J R Doyle; J P Fortin; M Beinborn; A S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2012-04-30       Impact factor: 4.030

Review 4.  Central nervous system agents for ischemic stroke: neuroprotection mechanisms.

Authors:  Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

5.  Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection.

Authors:  Pedram Hamrah; Zdenka Haskova; Andrew W Taylor; Qiang Zhang; Bruce R Ksander; M Reza Dana
Journal:  Transplantation       Date:  2009-07-27       Impact factor: 4.939

6.  Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.

Authors:  Hongchang Qu; Minying Cai; Alexander V Mayorov; Paolo Grieco; Morgan Zingsheim; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

7.  Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling.

Authors:  Biaoxin Chai; Ji-Yao Li; Weizhen Zhang; Hui Wang; Michael W Mulholland
Journal:  Peptides       Date:  2009-03-25       Impact factor: 3.750

Review 8.  Glial Cells Response in Stroke.

Authors:  Poonam Jadhav; Mayuri Karande; Abhishek Sarkar; Shubhrakanta Sahu; Deepaneeta Sarmah; Aishika Datta; Antra Chaudhary; Kiran Kalia; Arvind Sharma; Xin Wang; Pallab Bhattacharya
Journal:  Cell Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.046

9.  The synthetic melanocortin (CKPV)2 exerts anti-fungal and anti-inflammatory effects against Candida albicans vaginitis via inducing macrophage M2 polarization.

Authors:  Hai-xia Ji; Yu-lian Zou; Jing-jing Duan; Zhi-rong Jia; Xian-jing Li; Zhuo Wang; Li Li; Yong-wen Li; Gen-yan Liu; Ming-qing Tong; Xiao-yi Li; Guo-hui Zhang; Xiang-rong Dai; Ling He; Zhi-yu Li; Cong Cao; Yong Yang
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice.

Authors:  Eva-Verena Schaible; Arne Steinsträßer; Antje Jahn-Eimermacher; Clara Luh; Anne Sebastiani; Frida Kornes; Dana Pieter; Michael K Schäfer; Kristin Engelhard; Serge C Thal
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.